SG11201608489VA - Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody - Google Patents

Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody

Info

Publication number
SG11201608489VA
SG11201608489VA SG11201608489VA SG11201608489VA SG11201608489VA SG 11201608489V A SG11201608489V A SG 11201608489VA SG 11201608489V A SG11201608489V A SG 11201608489VA SG 11201608489V A SG11201608489V A SG 11201608489VA SG 11201608489V A SG11201608489V A SG 11201608489VA
Authority
SG
Singapore
Prior art keywords
hcenc
enrichment
characterization
monoclonal antibody
endothelial cells
Prior art date
Application number
SG11201608489VA
Inventor
Mei Yee Vanessa Ding
Boon Hwa Andre Choo
Chui Ping Angela Chin
Jodhbir Singh Mehta
Gary Peh
Original Assignee
Agency Science Tech & Res
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res, Singapore Health Serv Pte Ltd filed Critical Agency Science Tech & Res
Publication of SG11201608489VA publication Critical patent/SG11201608489VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0621—Eye cells, e.g. cornea, iris pigmented cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201608489VA 2014-04-11 2014-04-11 Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody SG11201608489VA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SG2014/000161 WO2015156734A1 (en) 2014-04-11 2014-04-11 Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody

Publications (1)

Publication Number Publication Date
SG11201608489VA true SG11201608489VA (en) 2016-11-29

Family

ID=54288177

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608489VA SG11201608489VA (en) 2014-04-11 2014-04-11 Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody

Country Status (3)

Country Link
US (1) US10287547B2 (en)
SG (1) SG11201608489VA (en)
WO (1) WO2015156734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2788472T (en) 2011-12-06 2019-04-01 Astellas Inst For Regenerative Medicine Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
US10428312B2 (en) * 2013-12-03 2019-10-01 Agency For Science, Technology And Research Cytotoxic antibody
CN107446027B (en) * 2017-09-05 2019-11-12 苏州大学 With the transdermal small peptide and its application for appraising and deciding capability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013036754A2 (en) * 2011-09-09 2013-03-14 The Wistar Institute Of Anatomy And Biology Methods and compositions for diagnosis of ovarian cancer

Also Published As

Publication number Publication date
US20170037366A1 (en) 2017-02-09
WO2015156734A1 (en) 2015-10-15
US10287547B2 (en) 2019-05-14

Similar Documents

Publication Publication Date Title
IL304178A (en) Anti-gitr antibodies and methods of use thereof
IL279606A (en) Anti-trem2 antibodies and methods of use thereof
HK1243102A1 (en) Anti-cd79b antibodies and methods of use
HRP20181359T1 (en) Anti-jagged1 antibodies and methods of use
IL251868B (en) Anti-tim3 antibodies and methods of use
HK1254743A1 (en) Novel anti-claudin antibodies and methods of use
IL251128A0 (en) Bispecific antibodies and methods of use in ophthalmology
IL248399A0 (en) Novel antii-rnf43 antibodies and methods of use
IL251165A0 (en) Anti-il-1beta antibodies and methods of use
ZA201701674B (en) Novel anti-mfi2 antibodies and methods of use
IL251477A0 (en) Anti-ang2 antibodies and methods of use
IL247754A0 (en) Anti-mcam antibodies and associated methods of use
IL251286A0 (en) Anti-pdgf-b antibodies and methods of use
SG11201608489VA (en) Enrichment and characterization of human corneal endothelial cells (hcenc) with novel monoclonal antibody